title: Mitozantrone and high-dose cytarabine in adult acute myeloid leukaemia.
authors.forename: R E
authors.initials: RE
authors.lastname: Marcus
authors.forename: D
authors.initials: D
authors.lastname: Catovsky
authors.forename: J M
authors.initials: JM
authors.lastname: Goldman
authors.forename: D A
authors.initials: DA
authors.lastname: Galton
authors.forename: A C
authors.initials: AC
authors.lastname: Newland
authors.forename: G
authors.initials: G
authors.lastname: Slocombe
authors.forename: U
authors.initials: U
authors.lastname: Hegde
mesh_terms: D000368:Aged; D000880:Anthraquinones / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D006801:Humans; D007263:Infusions, Parenteral; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone
chemical_list: D000880:Anthraquinones; D000970:Antineoplastic Agents; D003561:Cytarabine; D008942:Mitoxantrone